Loading

Black Canyon Bio

June 04, 2024
Start-Up Stadium Session
Oncology
5B
"Black Canyon Bio (BCB) is developing novel products for treating cancer using our proprietary Specific Neo-Antigen Peptides (SNAPTM) Technology platform. SNAPTM Technology has product development applications across many cancers and other diseases. SNAPTM Technology was developed by Dr. Sunil Sharma and his team at the Translational Genomics Research Institute (TGen), part of the City of Hope Medical Network. BCB’s first two products, SNAPTM-Vac (a personalized cancer vaccine) and SNAPTM-TIL (a personalized cellular therapy), will start human clinical testing in 2024. The market for cancer vaccines and cellular therapies is expected to grow exponentially during the next decade."
Company Website: http://www.blackcanyonbio.com

Company HQ City

Phoenix

Company HQ State

AZ

Company HQ Country

United States

CEO/Top Company Official

Ken Carter
Speakers
Ken Carter
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS